nmdp logo

NMDP Physician Exchange: Myelodysplastic Syndromes roundtable learning activity

Education for fellows, early-career and other clinicians

Release date: Oct. 17, 2024

Live event: Sept. 4, 2024

Access on-demand CME learning activity

Program overview

A panel of junior physicians in hematology/oncology and transplant discuss allogeneic hematopoietic cell transplant (HCT) in the management of adult patients with high-risk myelodysplastic syndrome (MDS). As they discuss specific patient cases and clinical scenarios, they cover research, tools, clinical trials, best practices and shared challenges when considering HCT for this patient population.

Earn up to 1.0 CME credit.

Target audience

This CME activity is intended for fellows, early career and other clinicians who treat patients with MDS or who specialize in hematology/oncology or HCT.

Learning objectives

Upon completion of this course, the learners should be better able to:

  • Identify shared challenges in MDS treatment among hematology/oncology and transplant teams
  • Examine current research, tools and clinical trials considered in the treatment of MDS with transplant
  • Describe best practices in MDS risk stratification, timing and eligibility for transplant

Faculty

Minoo Battiwalla, MD (moderator)
Director, Outcomes Research
Sarah Cannon Transplant and Cell Therapy Network

Manuel Espinoza Gutarra, MD
Assistant Professor
University of Alabama at Birmingham

Onyee Chan, MD
Assistant Member
Malignant Hematology, Moffitt Cancer Center

Assistant Professor
Oncologic Sciences, University of South Florida

Clark Alsfeld, MD
Attending Physician
Ochsner MD Anderson Cancer Center
Ochsner Health

Warren Fingrut, MD
Assistant Professor
Department of Stem Cell Transplantation and Cellular Therapy
University of Texas MD Anderson Cancer Center

Taha Al-Juhaisi, MD
Assistant Professor of Medicine
Stem Cell Transplantation and Cellular Therapy Program
Department of Medicine – Section of Hematology and Medical Oncology
University of Oklahoma Health Sciences Center – Stephenson Cancer Center

This activity is certified by Medical Learning Institute, Inc. for physicians.

Resources

Disease-specific HCT consultation guidelines and outcomes

Post-transplant care guidelines